Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial. - Perkovic V; Trimarchi H; Tesar V; Lafayette R; Wong MG; Barratt J; Suzuki Y; Liew A; Zhang H; Carroll K; Jha V; Quevedo A; et al. (The New England journal of medicine, 2026)